Background: Hypertension is a chronic medical condition in which blood pressure in the arteries is elevated. Given the large proportion of dental implant patients using antihypertensive medications, it is crucial to evaluate the effects of these drugs on the clinical parameters of osseointegrated implants. The aim of the present retrospective cohort study was to evaluate the influence of antihypertensive medications on clinical peri-implant tissue parameters.Methods: Thirty-five patients received a total of 77 anodized dental implants. Based on the history of the use of antihypertensive medications, the patients were divided into two groups: the group taking antihypertensive medications (AH group) and the group of healthy patients (H group). Implants were followed up clinically and radiologically, with a focus on the peri-implant soft tissue parameters probing pocket depth, bleeding on probing, modified plaque index, and marginal peri-implant bone level stability.Results: None of the implants were lost, and no technical failures occurred. The mean follow-up duration was 7 years and 1 month. A significant difference was observed in the probing pocket depth 3.8 ± 1.3 mm in the AH group and 3.0 ± 0.7 mm in the H group. In the AH and H groups, 26.5% (9/34) and 4.7% (2/43) of the patients were diagnosed with peri-implantitis at the implant level, respectively.Conclusions: Our findings suggest some correlations between antihypertensive medication use and clinical parameters in anodized peri-implant tissue.

Older patients inevitably have a higher need for implant treatment, it is unknown how mental changes or psychological aspects affect the outcome of implant treatment. This study evaluated the success rate of implants and the influence of personality traits in the older people. The goal was to provide evidence for predictable implant treatment while taking into account the unique psychological changes of elders. Participants were patients who were able to independently visit our hospital between March 2004 and May 2021. Inclusion criteria were patients aged 65 years or older at the time of implant placement with regular follow-up for at least 1 year. The implant success rate was calculated by counting peri-implantitis and implant loss as failures. Multivariate analysis was used to examine the effect of patient personality characteristics on the success rate. Fifty-six implants were included in 23 patients (12 men, 11 women), with a mean age of 68.5 years (65–76) and mean maintenance duration of 9 years and 2 months. The cumulative survival rate was 87% at the patient level (94.6% at the implant level). Statistically significant differences were found for adaptive traits (odds ratio [OR] = 0.04) and non-adaptive traits (OR = 6.38); however, no significant differences were found for the other independent variables. The overall implant success rate was 69.6% at the patient level (82.1% at the implant level). The personality traits in older people had a significant effect on the implant failure rate.

The pathophysiology and pathology of peri-implantitis remain unclear; however, its similarity to periodontitis has been described. The evaluation of peri-implant tissue and the diagnostic criteria of peri-implant disease are not currently standardized as they are for periodontitis. In this study, we evaluated clinical parameters during the implant maintenance period to determine significant correlations between these parameters. We examined 55 implant patients at the time of maintenance visits between April and September 2016 and classified patients into a healthy group (H) and a history-of-periodontitis group (HP). For each implant, we evaluated the modified plaque index, probing pocket depth, and bleeding on probing as clinical parameters. Statistical analyses were performed with Spearman’s rank correlation coefficient. A total of 130 implants were assessed. The mean time since implant placement was 6 years and 6 months. The prevalence of implant-based peri-implantitis was 10.8% of all the implants. All cases of implant-based peri-implantitis came from the HP group, and many were present in patients with a history of severe periodontitis. The probing pocket depth around the implant was significantly greater in the HP group than in the H group. We found weak positive correlations between the probing pocket depth and bleeding on probing (r s = 0.401, p < 0.05) in the H group and between the probing pocket depth and bleeding on probing (r s = 0.241, p < 0.05) and the modified plaque index (r s = 0.228, p < 0.05) in the HP group. Our findings suggest that probing pocket depth and bleeding on probing as clinical parameters are important indicators for the diagnosis of peri-implant disease during the maintenance period among healthy and history-of-periodontitis groups.

Osteoporosis is often detected late and becomes severe because of a lack of subjective symptoms. Digital panoramic radiography (DPR) has been reported to be useful for osteoporosis screening based on the morphological classification of the mandibular inferior cortex. The purpose of this study was to evaluate the sensitivity and specificity of the mandibular cortical index (MCI) in the diagnosis of osteoporosis in a group of patients who were and were not using antiosteoporosis medication (AOM). Three hundred and fifty female patients aged 40 years or older who had DPR imaging performed during a 6-year period from December 2015 to February 2022 met the selection criteria. Two examiners recorded mandibular cortical width and MCI from the images. These results were statistically examined together with the patients’ demographic data. Forty-nine patients were using AOM (13 nonbisphosphonate/denosumab and 36 bisphosphonate/denosumab). MCI type 3 was the most common in the AOM group. In the MCI classification, DPR imaging among the AOM group was more sensitive (0.95) than that of the control group. This method of estimating osteoporosis based on MCI classification using DPR images has high sensitivity, especially in patients using AOM, suggesting that this method is useful as a screening test.